Intraductal Meibomian Gland Probing Trial

Completed · Phase 4 · Has a placebo group

Conditions studied: Meibomian Gland Dysfunction

In brief

In this research study, the investigators are looking at the effects of Meibomian Gland Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have already tried traditional management with no success in resolving their clinical signs (as seen by their ophthalmologist) or their symptoms. The investigators are also evaluating the effects of using two (2) post-procedural medication treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after the MGP procedure has an effect on its outcome.

Key facts

Study ID
NCT02256969
Run by
Joseph B. Ciolino, MD
People needed
45
Starts
2014-10-01
Expected to finish
2015-08-01
Last updated by the study team
2017-06-19

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.